Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
09/27 TOBIRA THERAPEU : TBRA) Set to be Acquired by Allergan (AGN) as Ceni..
09/27 ALLERGAN : Receives FDA Approval to Market Natrelle Inspira Breast I..
09/26 ACQUISITION OF : TBRA) Under Investigation for Investors
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Allergan, Inc. operates as a global healthcare company.It engages in the developing and commercializing innovative specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity... 
Sector
Pharmaceuticals
Calendar
10/25Earnings Release
More about the company
Latest news on ALLERGAN, INC.
09/27 TOBIRA THERAPEUTICS : TBRA) Set to be Acquired by Allergan (AGN) as Cenicriviroc..
09/27 ALLERGAN : Receives FDA Approval to Market Natrelle Inspira Breast Implants
09/26 ACQUISITION OF TOBIRA THERAPEUTICS I : TBRA) Under Investigation for Investors
09/25 5 TOP NASDAQ BIOTECH STOCKS : Tobira Therapeutics Gains 752 Percent
09/25 ALLERGAN : CEO of drugs giant blasts ‘egregious' price hikes
09/24 ALLERGAN : to buy three companies for combined $2.4 billion
09/24 ALLERGAN : CEO of drugmaker blasts 'egregious' price hikes Allergan boss says ph..
09/23 TWO SPECULATIVE NASH ALLOCATIONS POS : AGN)’s Tobira Therapeutics Inc (NAS..
09/23 ALLERGAN : to buy three companies for combined $2.4 billion
09/21 ALLERGAN PLC (NYSE : AGN) Buys Two Biotech Companies In One Day
More news
Sector news : Pharmaceuticals - NEC
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
09/26 MYLAN : faces scrutiny over EpiPen profit data shown to Congress
09/26DJPFIZER : Throws Out Plan to Split Into Two Companies -- 2nd Update
09/26DJPfizer Throws Out Plan to Split Into Two Companies
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON14.66%322 232
ROCHE HOLDING LTD.-11.18%215 081
NOVARTIS AG-8.70%211 231
PFIZER INC.4.21%204 049
MERCK & CO., INC.17.66%171 858
More Results